Paloma Partners’s Compugen CGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-67,351
Closed -$217K 1191
2022
Q1
$217K Sell
67,351
-28,564
-30% -$96.5K 0.01% 1347
2021
Q4
$412K Buy
95,915
+60,263
+169% +$326K 0.01% 1213
2021
Q3
$213K Buy
+35,652
New +$239K 0.01% 831
2021
Q2
Sell
-77,600
Closed -$666K 1830
2021
Q1
$666K Buy
77,600
+57,081
+278% +$633K 0.01% 928
2020
Q4
$249K Buy
+20,519
New +$283K 0.01% 1259
2018
Q1
Sell
-42,181
Closed -$105K 1974
2017
Q4
$105K Buy
+42,181
New +$125K ﹤0.01% 1792

Other funds holding CGEN

Paloma Partners's CGEN Position: Q2 2022 in Review

Paloma Partners sold out of Compugen (CGEN) in Q2 2022, closing a stake of 67,351 shares — an estimated $217K sold.

Paloma Partners first reported a position in CGEN in Q4 2017 and held it in 6 quarters. The position peaked at $666K in Q1 2021. 89 funds tracked by Wall St. Rank hold CGEN as of Q2 2022.

  • Paloma Partners reported no remaining Compugen position as of Q2 2022 after selling out during the quarter.
  • Paloma Partners sold 67,351 Compugen shares in Q2 2022, an estimated $217K.
  • Paloma Partners first reported a position in Compugen in Q4 2017 and held it in 6 quarters.
  • Paloma Partners's Compugen position peaked at $666K in Q1 2021.
  • 89 funds tracked by Wall St. Rank held Compugen as of Q2 2022.

Based on Paloma Partners's 13F filing for Q2 2022, filed 15 Aug 2022.